Long-run onco-functional outcomes following mapping-guided supratotal resection in awake patients with IDH-mutated grade 2 gliomas

Preliminary results suggested a benefit of supratotal resection (SupTR) in grade 2 gliomas (G2G). However, long-term results are lacking in the molecular era. Here, long-run onco-functional outcomes are investigated following functional-guided SupTR of G2G. Patients who underwent awake mapping-based SupTR (additional resection margin beyond the presurgical FLAIR hypersignal) for IDH-mutated G2G were selected. Patients with no recurrence were compared to patients with tumor relapse that led to new treatment(s). This consecutive experience comprised 55 patients (29 men [52.7%], mean age 38.2 ± 10.4 years) with incidental discovery in 35 cases (63.6%) and epilepsy in 20 cases (36.4%). The mean KPS score was 98.4 ± 4.6 with 49 working patients (89%). The mean preoperative tumor volume was 14.1 ± 11.5 cc. All resections were continued up to functional networks identified by cortico-axonal stimulation in awake patients. There was no postoperative permanent impairment. The mean postoperative KPS score was 97.4 ± 5.2, with 47/49 patients who returned to work (95.9%). There were 30 IDH-mutated astrocytomas (54.5%) and 25 oligodendrogliomas (45.5%). No early adjuvant therapy was administered. During the follow-up, due to tumor relapse in 23 patients (41.8%), 19 of them underwent reoperation(s) and 9 had chemotherapy (including 3 with radiotherapy). The time to next intervention was 5.7 years (range 0.9–15.3). With a median follow-up of 9 years (range 0.3–23.3), the median OS was not reached (one patient died). The 5- and 10-year estimated OS rates were 100% and 94.1%, respectively. At last evaluation, 53/55 patients (96.4%) had a KPS ≥ 80. A lower risk of relapse was correlated with a smaller preoperative tumor volume ( p = 0.002) and the absence of antiepileptic cover ( p = 0.01). This original data detailing the long-lasting onco-functional outcomes after awake SupTR for IDH-mutated G2G evidenced a prolonged survival with a long-term preservation of quality of life. Such findings support early mapping-based SupTR in awake patients.

Authors

Institutions

Publication Details

Journal
Acta Neurochirurgica
Published
2026-11-21
DOI
https://doi.org/10.1007/s00701-026-07099-5
Primary Topic
Glioma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Long-run onco-functional outcomes following mapping-guided supratotal resection in awake patients with IDH-mutated grade 2 gliomas

Hugues Duffau
Acta Neurochirurgica
Glioma Diagnosis and Treatment
article

Long-run onco-functional outcomes following mapping-guided supratotal resection in awake patients with IDH-mutated grade 2 gliomas

Hugues Duffau
article en

Abstract

Preliminary results suggested a benefit of supratotal resection (SupTR) in grade 2 gliomas (G2G). However, long-term results are lacking in the molecular era. Here, long-run onco-functional outcomes are investigated following functional-guided SupTR of G2G. Patients who underwent awake mapping-based SupTR (additional resection margin beyond the presurgical FLAIR hypersignal) for IDH-mutated G2G were selected. Patients with no recurrence were compared to patients with tumor relapse that led to new treatment(s). This consecutive experience comprised 55 patients (29 men [52.7%], mean age 38.2 ± 10.4 years) with incidental discovery in 35 cases (63.6%) and epilepsy in 20 cases (36.4%). The mean KPS score was 98.4 ± 4.6 with 49 working patients (89%). The mean preoperative tumor volume was 14.1 ± 11.5 cc. All resections were continued up to functional networks identified by cortico-axonal stimulation in awake patients. There was no postoperative permanent impairment. The mean postoperative KPS score was 97.4 ± 5.2, with 47/49 patients who returned to work (95.9%). There were 30 IDH-mutated astrocytomas (54.5%) and 25 oligodendrogliomas (45.5%). No early adjuvant therapy was administered. During the follow-up, due to tumor relapse in 23 patients (41.8%), 19 of them underwent reoperation(s) and 9 had chemotherapy (including 3 with radiotherapy). The time to next intervention was 5.7 years (range 0.9–15.3). With a median follow-up of 9 years (range 0.3–23.3), the median OS was not reached (one patient died). The 5- and 10-year estimated OS rates were 100% and 94.1%, respectively. At last evaluation, 53/55 patients (96.4%) had a KPS ≥ 80. A lower risk of relapse was correlated with a smaller preoperative tumor volume ( p = 0.002) and the absence of antiepileptic cover ( p = 0.01). This original data detailing the long-lasting onco-functional outcomes after awake SupTR for IDH-mutated G2G evidenced a prolonged survival with a long-term preservation of quality of life. Such findings support early mapping-based SupTR in awake patients.

Acta Neurochirurgica
Inserm (FR), Hôpital Gui de Chauliac (FR)
Glioma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon